期刊文献+

树突状细胞致免疫耐受的研究进展 被引量:2

下载PDF
导出
摘要 树突状细胞( DC )是高特异性的抗原递呈细胞,它收集各种输入信号,介导免疫反应;双向调节抗原负载T细胞免疫反应或诱导免疫耐受,同时在自身免疫性疾病或移植耐受研究中起重要作用。现结合文献就DC致免疫耐受的研究进展作一综述。
出处 《山东医药》 CAS 2014年第13期87-89,共3页 Shandong Medical Journal
基金 重庆市自然科学基金资助项目(cstc2012jjA10002) 重庆市卫生局基金资助项目(20122296)
  • 相关文献

参考文献16

  • 1Watowich SS, Liu YJ. Mechanisms regulating dendritic cell speci- fication and development [ J ]. lmmunol Rev, 2010,238 ( 1 ) : 76-92.
  • 2Rulle S, Ah Kioon MD, Asensio C, et al. a neuropeptide with im- munoregulatory properties induces semi-mature tolerogenic dendritic ceils [ J ]. Immunology, 2012,136 ( 2 ) : 252-264.
  • 3Nicolaou N. Conference scene: antigen-presenting cells: different approaches to immune induction and tolerance [ J ]. Immunothera- py, 2012,4( 11 ) :1095-1097.
  • 4Harden JL, Egilmez NK. Indoleamine 2,3-dioxygenase and den- dritic cell tolerogenicity [ J ]. Immunol Invest, 2012,41 ( 6-7 ) : 738 -764.
  • 5Chu CC, Ali N, Karagiannis P, et al. Resident CD141 ( BDCAB ) + dendritic cells in human skin produce IL-IO and induce regula- tory T cells that suppress skin inflammation [ J ]. J Exp Med, 2012,209 (5) :935-945.
  • 6De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, et al. Im- munosuppressive properties of mesenchymal stem ceils: advances and applications[J]. Curt Mol Med, 2012,12(5) :574-591.
  • 7Walter G J, Evans HG, Menon B, et al. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4 + CD45ro + CD25 + CD127 (low) regulatory T cells [J]. Arthritis Rheum, 2013,65(3) :627-638.
  • 8Zhan Y, Vega-Ramos J, Carrington EM, et al. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells[J]. Eur J Immunol, 2012,42( 11 ) :2889-2900.
  • 9Nicolaou N. Conference scene: antigen-presenting cells: different approaches to immune induction and tolerance [ J ]. Immunothera- py, 2012,4 ( 11 ) : 1095-1097.
  • 10Nahid MA, Yao B, Dominguez-Gutierrez PR, et al. Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modu- lation by miR-132 and miR-212[J]. J Immunol, 2013,190(3): 1250-1263.

同被引文献27

  • 1Gelao L, Criscitiello C, Esposito A, et al. Dendritic cell-based vaccines: clinical applications in breast cancer [ J ]. Immunotherapy, 2014, 6(3) : 349 -360.
  • 2Apostolopulos V, Pietersz G A, Tsibanis A, et al. Dendritic cell immunotherapy: clinical outcomes [ J/OL]. Clin Transl Immunology, 2014, 3(7): e21. doi: 10. 1038/cti. 2014. 14. eCollection 2014.
  • 3Weber J S. Current perspectives on immunotherapy [ J ]. Semin Oncol, 2014, 41 (Suppl 5) : S14 -S29.
  • 4Sharma A, Koldovsky U, Xu S, et al. HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma insitu[J]. Cancer, 2012, 118(17):4354-4362.
  • 5Bakocevic N, Worbs T, Davalos-Misslitz A, et al. T cell-dendritic cell interation dynamics during the induction of respiratory tolerance and immunity[J]. J Imnmnol, 2010, 184(3) : 1317 -1327.
  • 6Anguile S, Smits E L, Lion E, et al. Clinical use of dendritic cells for cancer therapy [ J/OL ]. Lancet Oncol, 2014, 15 ( 7 ) : e257 - e267. doi. 10. 1016/S1470 - 2045 ( 13 ) 70585 - 0.
  • 7Declerk S, Vansteenkiste J. Immunotherapy for lung cancer : ongoing clinical trials[ J].Future Oncol, 2014, 10( 1 ) : 91 -105.
  • 8Xie Z X, Zhang H L, Wu X J, et al. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis [ J/OL ]. Mediators Inflamm, 2015, 2015: 513295. doi: 10. 1155/2015/ 513295. Epub 2015 Jan 29.
  • 9Chapuis F, Rosenzwajg W, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro[ J]. Eur J Immunol, 1997, 27(2) : 431 -441.
  • 10Osada T, Nagaoka K, Takahara M, et al. Precision cance immunothempy: Optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors [ J ]. J Immunother, 2015, 38(4) : 155 -164.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部